GSP Neonatal Creatine Kinase - MM Kit
Muscular Dystrophy Newborn Screening Test
PerkinElmer Inc.
The following data is part of a De Novo classification by Perkinelmer Inc. with the FDA for Gsp Neonatal Creatine Kinase - Mm Kit.
Pre-market Notification Details
DeNovo ID | DEN180056 |
Device Name: | GSP Neonatal Creatine Kinase - MM Kit |
Classification | Muscular Dystrophy Newborn Screening Test |
Applicant | PerkinElmer Inc. 940 Winter Street Waltham, MA 02451 |
Contact | Brian Ciccariello |
Product Code | QJE |
CFR Regulation Number | 862.1506 [🔎] |
Decision | Granted (DENG) |
510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
Review Advisory Board | Clinical Chemistry |
Classification Advisory | Clinical Chemistry |
Type | Direct |
Date Received | 2018-10-11 |
Decision Date | 2019-12-12 |
Reclassification Order: | Reclassification Order |
NIH GUDID Devices
Device Identifier | submissionNumber | Supplement |
06438147362615 |
DEN180056 |
000 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.